TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

Benzinga Logo Benzinga By Business Wire
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21-November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 after its stock price spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors must contact the firm by February 17, 2026.

Insights
BAM   positive

Highlighted as a leading global alternative asset manager with over US$1 trillion in assets under management


MCTA   negative

The company is the subject of a securities fraud class action lawsuit, faced an SEC trading suspension in November 2025, and is accused of making false and misleading statements to the market. The suspension was triggered by allegations of a promotion scheme artificially inflating stock prices, resulting in investor damages.